Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Sagimet Biosciences Inc. (SGMT) had Return on Tangible Equity of -7.98% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-10.39M |
|
-- |
|
-- |
|
$11.93M |
|
$-11.93M |
|
$1.54M |
|
$-10.39M |
|
$-10.39M |
|
$-10.39M |
|
$-10.39M |
|
$-10.39M |
|
$-10.39M |
|
$-11.93M |
|
$-12.15M |
|
32.20M |
|
32.20M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$127.20M |
|
-- |
|
$10.21M |
|
$137.41M |
|
$7.25M |
|
-- |
|
-- |
|
$7.25M |
|
$130.16M |
|
$130.16M |
|
$130.16M |
|
32.20M |
|
| Cash Flow Statement Financials | |
$-23.64M |
|
$-9.88M |
|
$0.00M |
|
$75.84M |
|
$42.33M |
|
$-33.51M |
|
$3.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.98% |
|
|
Return on Tangible Equity |
-7.98% |
-7.56% |
|
-7.98% |
|
$4.04 |
|
$-0.73 |
|
$-0.73 |
|